Evaluate the efficacy of Shatapushpadi Basti in the management of Prameha (Diabetes mellitus)

Randomized controlled clinical study to evaluate the efficacy of Shatapushpadi Basti in the management of Prameha (Diabetes mellitus) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/077076

Enrollment

Registered

2024-11-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed patient of prameha . Patient with Diabetes mellitus type II. Subject having their fasting blood sugar more than 126 mg/dl and postmeal sugar more than 200mg/dl, B.M.I range 18 to 25 kg/m2 Basti chikitsa yogya patients. Patient willing for trial and giving written consent.

Exclusion criteria

Exclusion criteria: Patient below age 30 and above 60 years. patient with diabetes type I. DM associated with following condition - Pregnancy ,Lactating women ,moderate to sever cardiovascular disease aand kidney disorder ,k/c/o any malignancy,k/c/o TB

Design outcomes

Primary

Measure	Time frame
Polyuria will be decreased Polydipsia will be decreased Polyphagia will be decreased. Timepoint: 24 days	—

Secondary

Measure	Time frame
Perspiration will be decreased. Burning sensation will be decreased. Tingling sensation will be decreased.Timepoint: 24 days	—

Countries

India

Contacts

Public ContactDr Ekta Suryabhan Tanderkar

C.S.M.S.S. Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra India 431011

uneralkar@gmail.com9850035061

Outcome results